Brief: Onxeo closes DNA Therapeutics acquisition
25/03/2016 17:00
March 25 (Reuters) - Onxeo SA C4X.PA :
* Announces closing of DNA Therapeutics acquisition
Source text for Eikon: urn:newsml:reuters.com:*:nBw6QP7rwa
Further company coverage: C4X.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln